Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 17.525 -0.295 (-1.66%) Market Cap: 473.92 Mil Enterprise Value: 252.44 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 74/100

Q4 2021 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

Feb 28, 2022 / 09:30PM GMT
Release Date Price: $23.97 (+1.40%)
Operator

Greetings. Welcome to the Arcturus Therapeutics Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Deepankar Roy, Senior Director of Investor Relations. You may begin.

Deepankar Roy

Thank you, Kyle. Good afternoon, and welcome to Arcturus Therapeutics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Call. Thank you all for joining us. Today's call will be led by Joseph Payne, President and CEO; Andy Sassine, our CFO; and Dr. Pad Chivukula, our CSO and COO.

Before we begin, I would like to remind everyone that statements made during this call regarding matters that are not historical facts are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements are not guarantees of performance, and they involve known and unknown risks, uncertainties and assumptions that may cause actual results to vary. So performance and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot